Apogee Therapeutics, Inc. Insider Transactions
Apogee Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
| Sell | 14,000 @ $59.17 | $828.38 K | 1,340,487 | 11/06/2024 | 11/08/2024 | ||
|
Dambkowski Carl
Chief Medical Officer |
Sell | 5,740 @ $56.16 | $322.36 K | 275,053 | 10/02/2024 | 10/04/2024 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 925 @ $56.86 | $52.60 K | 274,128 | 10/02/2024 | 10/04/2024 | |
| Sell | 30,288 @ $56.07 | $1.70 M | 1,364,199 | 10/02/2024 | 10/04/2024 | ||
| Sell | 9,712 @ $56.74 | $551.06 K | 1,354,487 | 10/02/2024 | 10/04/2024 | ||
| Sell | 25,641 @ $47.28 | $1.21 M | 1,408,846 | 09/04/2024 | 09/06/2024 | ||
| Sell | 14,359 @ $48.23 | $692.54 K | 1,394,487 | 09/04/2024 | 09/06/2024 | ||
|
Dambkowski Carl
Chief Medical Officer |
Sell | 787 @ $48.06 | $37.82 K | 280,793 | 09/04/2024 | 09/06/2024 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 5,878 @ $47.49 | $279.15 K | 281,580 | 09/04/2024 | 09/06/2024 | |
|
Henderson Jane
CFO |
Sell | 6,000 @ $48.26 | $289.56 K | 200,871 | 08/23/2024 | 08/23/2024 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 6,523 @ $40.47 | $263.99 K | 288,270 | 08/07/2024 | 08/09/2024 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 142 @ $41.09 | $5.84 K | 288,128 | 08/07/2024 | 08/09/2024 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 670 @ $42.56 | $28.52 K | 287,458 | 08/07/2024 | 08/09/2024 | |
| Sell | 32,233 @ $40.40 | $1.30 M | 1,442,254 | 08/07/2024 | 08/09/2024 | ||
| Sell | 7,667 @ $41.52 | $318.33 K | 1,434,587 | 08/07/2024 | 08/09/2024 | ||
| Sell | 100 @ $42.17 | $4.22 K | 1,434,487 | 08/07/2024 | 08/09/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apogee Therapeutics, Inc. FAQ's
The list of insiders at Apogee Therapeutics, Inc. includes Dambkowski Carl, McKenna Mark C., HENDERSON MICHAEL THOMAS.
Insiders have sold a total of 53.74 K Apogee Therapeutics, Inc. shares in the last 12 months for a total of 2.25 M sold.
The following insiders have sold Apogee Therapeutics, Inc. shares in the last 12 months: Dambkowski Carl ($604.79 K), HENDERSON MICHAEL THOMAS ($1.64 M),
Insiders have purchased a total of 20.00 K Apogee Therapeutics, Inc. shares in the last 12 months for a total of 990.78 K.
The following insiders have purchased Apogee Therapeutics, Inc. shares in the last 12 months: McKenna Mark C. ($990.78 K),